VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Thryv

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 25 out of 100

  • Biotech & therapeutics
Claim, correct or request removal

Record updated 20 September 2026

About

Thryv has a first-in-class treatment for a rare pediatric cardiology disease called Long QT Syndrome that demonstrated strong efficacy signal in its Phase 2a study.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy